Trial intelligence / Profile preview

Paracervical block versus paracervical block plus fundal anesthesia during outpatient NovaSure endometrial ablation

NL-OMON26448Not yet recruiting

Sponsor
Máxima Medisch Centrum
Start
Nov 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of ropivacaine and sodium chloride in hypermenorrhea (2 arms), sponsored by Máxima Medisch Centrum. Primary endpoint: Pain intensity 1 minute into active ablation. Planned start Nov 2015; status: not yet recruiting.

02

Drugs

ropivacainesodium chloride
03

Conditions

hypermenorrhea

Beyond the preview

Go deeper on NL-OMON26448.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON26448.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call